Westchester Capital Management (New York)’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History
Bought
Maintained
Sold
Other funds holding AONC
CH
SCM
AIMCA
AA
UOC
GCL
FTCM
SCM
KIM
MSU
Westchester Capital Management (New York)'s AONC Position: Q1 2023 in Review
Westchester Capital Management (New York) sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 593,690 shares — an estimated $5.96M sold.
Westchester Capital Management (New York) first reported a position in AONC in Q1 2022 and held it in 4 quarters. The position peaked at $5.96M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.
- Westchester Capital Management (New York) reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
- Westchester Capital Management (New York) sold 593,690 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $5.96M.
- Westchester Capital Management (New York) first reported a position in American Oncology Network, Inc. Class A Common Stock in Q1 2022 and held it in 4 quarters.
- Westchester Capital Management (New York)'s American Oncology Network, Inc. Class A Common Stock position peaked at $5.96M in Q4 2022.
- 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.
Based on Westchester Capital Management (New York)'s 13F filing for Q1 2023, filed 15 May 2023.